INIS
epidemiology
100%
data
87%
kazakhstan
83%
patients
61%
mortality
51%
pediatrics
50%
diseases
46%
diabetes mellitus
34%
kidneys
33%
children
31%
risks
26%
cardiovascular diseases
22%
comparative evaluations
20%
reviews
19%
dialysis
18%
therapy
17%
death
17%
malignancies
16%
nutrition
16%
juveniles
16%
arthritis
16%
ischemia
16%
management
16%
males
12%
sex
12%
females
11%
hazards
10%
leukemia
10%
lymphomas
10%
populations
8%
neoplasms
7%
arteries
7%
coronaries
7%
regression analysis
7%
screening
6%
clinical trials
6%
Keyphrases
Epidemiology
50%
Kazakhstan
50%
Electronic Health Systems
37%
Diabetes
33%
Type 1 and Type 2 Diabetes Mellitus
33%
High Risk
19%
All-cause Mortality
16%
Cardiovascular Disease
16%
Pediatric nutrition
16%
Biostatistics
16%
Diabetes Epidemiology
16%
Systemic Juvenile Idiopathic Arthritis (sJIA)
16%
Rheumatic Disorders
16%
Celiac Disease
16%
Dialysis Patients
16%
Dialysis
16%
European Associations
16%
End-stage Renal Disease Patients
16%
Pediatric
16%
Pediatric Hematological Malignancies
16%
Actovegin
16%
Mortality Outcomes
16%
Scottish
16%
Mortality Rate
15%
Kazakh
13%
Prevalence Rate
11%
Kazakh Population
9%
Comorbidity
9%
Incidence Rate
8%
Type 1 Diabetes Mellitus (T1DM)
8%
Risk of Death
8%
Confidence Interval
8%
Older Patients
8%
End-stage Renal Disease
8%
Survival Probability
8%
Young Ones
8%
Administrative Healthcare Data
6%
Cardiovascular Disease Incidence
6%
Primary Kidney Disease
6%
Young Age
5%
Neoplasms
5%
Diabetic Nephropathy
5%
Male Sex
5%
Old Age
5%
Amputation
5%
Coronary Artery Disease
5%
Nationality
5%
Medicine and Dentistry
Cohort Effect
83%
Health System
38%
Pediatrics
33%
Maturity Onset Diabetes of the Young
33%
Diabetes
33%
Prevalence
27%
All Cause Mortality
26%
Mortality Rate
21%
Cause of Death
19%
Coeliac Disease
16%
Biostatistics
16%
Juvenile Idiopathic Arthritis
16%
Epidemiology of Diabetes
16%
Rheumatic Disorder
16%
End Stage Renal Disease
16%
Cardiovascular Disease
16%
Hematologic Malignancy
16%
Pediatric Nutrition
16%
Actovegin
16%
Survival Rate
11%
Leukemia
10%
Coronary Artery Disease
9%
Neoplasm
9%
Diabetic Nephropathy
9%
Apoplexy
9%
Amputation
9%
Proportional Hazards Model
8%
Acute Myelogenous Leukemia
6%
Insulin Dependent Diabetes Mellitus
6%
Peritoneal Dialysis
5%
Hemodialysis
5%
Renal Replacement Therapy
5%
